Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Axsome Therapeutics is a US-based biopharmaceutical company dedicated to developing innovative therapies for central nervous system (CNS) neurological disorders. The company focuses on improving the quality of life for patients suffering from conditions such as depression, migraine, and narcolepsy through its pipeline of novel treatments.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Axsome Therapeutics is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Axsome Therapeutics last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.99 USD.
Across its last 3 earnings reports, Axsome Therapeutics stock moved by ±4.6% on average the following day. The largest reaction was +8.3% on 05/04/2026; 2 of 3 reactions were positive.
Axsome Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.